Westby Keith's Form 4 filing
IVERIC bio, Inc. (ISEE) · filed Feb 22, 2023
- Accession no.
- 0001410939-23-000016
- Filed
- Feb 22, 2023
- Trade date
- Feb 17, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $375.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Westby KeithCIK 0001696429 | Officer (SVP, Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common Stock | MOption exerciseAcquired | +3,786 | $2.94 | +$11,130.84 | 50,140 | Direct | |
| Feb 17, 2023 | Common Stock | SSaleDisposed | −3,786 | $25.05F2 | −$94,839.3 | 46,354 | Direct | |
| Feb 17, 2023 | Common Stock | MOption exerciseAcquired | +11,214 | $4.52 | +$50,687.28 | 57,568 | Direct | |
| Feb 17, 2023 | Common Stock | SSaleDisposed | −11,214 | $25.05F2 | −$280,910.7 | 46,354 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common Stock | MOption exerciseDisposed | −3,786 | $2.94 | −$11,130.84 | 146,214 | Direct | |
| Feb 17, 2023 | Common Stock | MOption exerciseDisposed | −11,214 | $4.52 | −$50,687.28 | 48,786 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $25.00 to $25.14 per share on February 17, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
Referenced by the price of 2 transactions in Table I.